Fidelity Investments’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305K Buy
193,308
+1,348
+0.7% +$2.27K ﹤0.01% 3314
2025
Q4
$321K Sell
191,960
-2,068
-1% -$3.58K ﹤0.01% 3243
2025
Q3
$328K Sell
194,028
-862
-0.4% -$1.02K ﹤0.01% 3191
2025
Q2
$177K Sell
194,890
-9,216
-5% -$5.47K ﹤0.01% 3356
2025
Q1
$92.2K Buy
204,106
+3,201
+2% +$1.88K ﹤0.01% 3589
2024
Q4
$101K Buy
200,905
+194,495
+3,034% +$143K ﹤0.01% 3544
2024
Q3
$5.8K Buy
6,410
+4,537
+242% +$4.21K ﹤0.01% 4590
2024
Q2
$1.87K Sell
1,873
-228
-11% -$252 ﹤0.01% 4734
2024
Q1
$3.11K Buy
2,101
+751
+56% +$851 ﹤0.01% 4615
2023
Q4
$1.47K Sell
1,350
-94
-7% -$103 ﹤0.01% 4703
2023
Q3
$1.7K Sell
1,444
-649
-31% -$883 ﹤0.01% 4576
2023
Q2
$2.95K Buy
2,093
+1,249
+148% +$1.73K ﹤0.01% 4503
2023
Q1
$1.27K Buy
844
+62
+8% +$87 ﹤0.01% 4709
2022
Q4
$915 Sell
782
-236
-23% -$297 ﹤0.01% 4669
2022
Q3
$1K Sell
1,018
-4,408
-81% -$6.47K ﹤0.01% 4697
2022
Q2
$9K Buy
5,426
+3,744
+223% +$4.94K ﹤0.01% 4143
2022
Q1
$2K Buy
1,682
+1,680
+84,000% +$2.61K ﹤0.01% 4676
2021
Q4
$0 Hold
2
﹤0.01% 4696
2021
Q3
$0 Sell
2
-3
-60% -$8 ﹤0.01% 4734
2021
Q2
$0 Buy
+5
New +$13 ﹤0.01% 4605
2020
Q1
Sell
-500
Closed 4001
2019
Q4
$0 Buy
+500
New +$417 ﹤0.01% 4067
2019
Q3
Sell
-493
Closed -$1K 4044
2019
Q2
$1K Buy
493
+473
+2,365% +$545 ﹤0.01% 3614
2019
Q1
$0 Buy
+20
New +$25 ﹤0.01% 3950
2014
Q1
Sell
-759,946
Closed -$2.21M 2688
2013
Q4
$2.21M Sell
759,946
-1,038,480
-58% -$3.14M ﹤0.01% 2333
2013
Q3
$5.52M Sell
1,798,426
-82,270
-4% -$260K ﹤0.01% 2131
2013
Q2
$6.01M Buy
+1,880,696
New +$6.02M ﹤0.01% 2086

Other funds holding LCTX